Clinical Trial Update: A Long-term Observational Study in Participants Who Have Received PBGENE-HBV

View source ↗

Summary

This update describes a long-term observational study following participants who have received PBGENE-HBV to assess outcomes in chronic hepatitis B infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• PBGENE-HBV

Snippet

Sponsor: Precision BioSciences, Inc. | Conditions: Chronic HBV Infection | Status: ENROLLING_BY_INVITATION